Reducing excessive toxicity in ovarian cancer treatment: a personalized approach

By Stampler Kate M   Holtz David O   Dunton Charles J  

Future Oncology, Vol. 7, Iss. 6, 2011-06 ,pp. : 789-798

Future Medicine

Access to resources Recommend Favorite

Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies

By Carrera S.   Buque A.   Azkona E.   Aresti U.   Calvo B.   Sancho A.   Arruti M.   Nuño M.   Rubio I.   Lobera A.   Lopez C.   Vivanco G.  

Clinical and Translational Oncology, Vol. 16, Iss. 4, 2014-04 ,pp. : 339-350

Springer Publishing Company

Access to resources Recommend Favorite

Epidermal growth factor receptor inhibitors in cancer treatment

By Ciardiello Fortunato  

Future Oncology, Vol. 1, Iss. 2, 2005-04 ,pp. : 221-234

Future Medicine

Access to resources Recommend Favorite

Targeting the Fibroblast Growth Factor Receptors for the Treatment of Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 5, 2013-06 ,pp. : 748-761

Bentham Science Publishers

Access to resources Recommend Favorite

Antiangiogenic Agents for the Treatment of Nonsmall Cell Lung Cancer: Characterizing the Molecular Basis for Serious Adverse Events

By Wu Shenhong   Keresztes Roger S.  

Cancer Investigation, Vol. 29, Iss. 7, 2011-07 ,pp. : 460-471

Informa Healthcare

Access to resources Recommend Favorite